Key points are not available for this paper at this time.
The 2025 Alzheimer's disease drug development pipeline hosts 182 trials and 138 novel drugs.The 2025 Alzheimer's disease drug development pipeline is diverse, with agents that address 15 basic disease processes.The 2025 Alzheimer's disease drug development pipeline has more trials and more drugs than the 2024 pipeline.Biomarkers play an important role in current trials to determine trial eligibility and as outcomes of trials.Repurposed agents comprise approximately one-third of the agents and trials in the 2025 Alzheimer's disease drug development pipeline.
Building similarity graph...
Analyzing shared references across papers
Loading...
Jeffrey L. Cummings
Yadi Zhou
Garam Lee
SHILAP Revista de lepidopterología
Alzheimer s & Dementia Translational Research & Clinical Interventions
Case Western Reserve University
University School
University of Nevada, Las Vegas
Building similarity graph...
Analyzing shared references across papers
Loading...
Cummings et al. (Tue,) studied this question.
www.synapsesocial.com/papers/69dcd0f6d111c0385b35936b — DOI: https://doi.org/10.1002/trc2.70098